首页> Future oncology> Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy

Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy

导出原文传递

翻译打印收藏纠错

第一作者： Guo, Dong

作者： Guo, Dong ^[1] ; Li, Minghuan ^[2] ; Chen, Dawei ; Jing, Wang ; Zhu, Hui ; Fu, Lei ; Kong, Li ; Yue, Jinbo ; Yu, Jinming

作者单位： Shandong Univ, Shandong Canc Hosp, Dept Radiotherapy, Jinan, Shandong, Peoples R China ^[1] Weifang Med Univ, Weifang, Peoples R China ^[2]

关键词 advanced chemotherapy first-line neutrophil-to-lymphocyte ratio non-small-cell lung cancer platelet-to-lymphocyte ratio platinum predictor prognostic superior

发布时间 2019-10-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Future oncology

2019年15卷6期

625-635页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Future oncology

2019年15卷6期

625-635页

检索历史清除

Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy

Future oncology

相似文献

同项目论文

Future oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy

Future oncology

相似文献

同项目论文

Future oncology

相关期刊

检索历史清除